Single dose of psilocybin repairs brain circuits in fetal alcohol syndrome mice

Key Findings

🌿 Ayahuasca Shows Promise Against Suicidal Thoughts

• Five studies consistently found that ayahuasca rapidly reduced suicidal ideation in patients with treatment-resistant depression

• The traditional Amazonian brew works by combining DMT with β-carbolines, promoting brain plasticity and reducing activity in the default mode network

• Effects appeared quickly and were linked to increased production of brain-derived neurotrophic factor, a protein that helps neurons grow and connect

🔬 Scientists Map How Psychedelics Create Hallucinations

• Researchers trained AI models to simulate the visual system, then mimicked psychedelic effects by shifting the models into a "dream-like" state

• This produced hallucinations that were coherent at a basic level but surreal overall—matching what humans experience on psychedelics

• The simulation worked by increasing top-down brain connections, supporting the theory that psychedelics make the brain more "dreamy" even while awake

💊 Psilocybin Rewires Brain Networks in Meth Addiction

• Brain scans before and after psilocybin treatment showed significant reorganization of attention, default mode, and salience networks in people with methamphetamine addiction

• Patients who reduced their meth use most showed the strongest recovery in frontal brain circuits that control decision-making

• Local brain synchrony increased in frontal and motor regions, suggesting improved neural coordination

⚠️ Ketamine Addiction Risk After Single Medical Dose

• A 25-year-old woman developed ketamine addiction after receiving just one intranasal dose in a clinical trial for suicidal thoughts

• She escalated to daily illicit ketamine and cocaine use within weeks, leading to financial distress and housing instability

• The patient had multiple psychiatric conditions including autism, depression, and anorexia, which may have increased her vulnerability

🧬 Ketamine's Antidepressant Effects Work Through Opioid Receptors

• Scientists found that ketamine's behavioral effects rely on mu-opioid receptors in specific brain cells called somatostatin interneurons

• Chronic stress causes these cells to become overactive, excessively inhibiting other neurons—ketamine reverses this damage

• Using this mechanism, researchers identified new drug targets that could provide antidepressant effects with fewer side effects

📊 HPPD Study Reveals Complex Pattern of Health Issues

• Analysis of 25,778 people diagnosed with hallucinogen persisting perception disorder found high rates of anxiety (26.2%), chronic pain (15.9%), and post-viral fatigue (12.3%)

• Anxiety and post-viral fatigue predicted who would develop HPPD among psychedelic users

• HPPD patients showed increased risk of functional somatic syndromes and psychiatric disorders compared to other psychedelic users